August 1, 2019 (Shanghai, China) – GenFleet Therapeutics completed the site initiation visit of Phase I trial for its first product granted with IND approval earlier this year.
November 30, 2018 (Shanghai, China) -- GenFleet Therapeutics recently announced the close of its series A financing worth 120 million yuan
